Singapore markets closed

Shockwave Medical, Inc. (SWAV)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
330.13-0.75 (-0.23%)
At close: 04:00PM EDT
328.43 -1.70 (-0.51%)
After hours: 04:44PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 12.42B
Enterprise value 12.17B
Trailing P/E 77.67
Forward P/E 69.44
PEG ratio (5-yr expected) N/A
Price/sales (ttm)16.10
Price/book (mrq)16.52
Enterprise value/revenue 15.44
Enterprise value/EBITDA 59.51

Trading information

Stock price history

Beta (5Y monthly) 0.88
52-week change 320.25%
S&P500 52-week change 326.36%
52-week high 3331.58
52-week low 3157.00
50-day moving average 3313.09
200-day moving average 3236.21

Share statistics

Avg vol (3-month) 31.1M
Avg vol (10-day) 3622.89k
Shares outstanding 537.54M
Implied shares outstanding 637.54M
Float 836.96M
% held by insiders 11.20%
% held by institutions 198.69%
Shares short (30 Apr 2024) 41.65M
Short ratio (30 Apr 2024) 40.86
Short % of float (30 Apr 2024) 44.94%
Short % of shares outstanding (30 Apr 2024) 44.39%
Shares short (prior month 28 Mar 2024) 42.03M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 20.75%
Operating margin (ttm)19.38%

Management effectiveness

Return on assets (ttm)8.68%
Return on equity (ttm)24.73%

Income statement

Revenue (ttm)787.97M
Revenue per share (ttm)21.34
Quarterly revenue growth (yoy)35.80%
Gross profit (ttm)N/A
EBITDA 180.34M
Net income avi to common (ttm)163.5M
Diluted EPS (ttm)4.27
Quarterly earnings growth (yoy)41.50%

Balance sheet

Total cash (mrq)1.03B
Total cash per share (mrq)27.41
Total debt (mrq)776.8M
Total debt/equity (mrq)103.33%
Current ratio (mrq)13.81
Book value per share (mrq)20.04

Cash flow statement

Operating cash flow (ttm)197.93M
Levered free cash flow (ttm)118.03M